378 related articles for article (PubMed ID: 31221971)
21. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
[TBL] [Abstract][Full Text] [Related]
22. Aging impairs protective host defenses against Clostridioides (Clostridium) difficile infection in mice by suppressing neutrophil and IL-22 mediated immunity.
Peniche AG; Spinler JK; Boonma P; Savidge TC; Dann SM
Anaerobe; 2018 Dec; 54():83-91. PubMed ID: 30099125
[TBL] [Abstract][Full Text] [Related]
23. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.
Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS
Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683
[No Abstract] [Full Text] [Related]
24. Immune responses induced by Clostridium difficile.
Péchiné S; Collignon A
Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
[TBL] [Abstract][Full Text] [Related]
25. IL-17-producing γδ T cells protect against Clostridium difficile infection.
Chen YS; Chen IB; Pham G; Shao TY; Bangar H; Way SS; Haslam DB
J Clin Invest; 2020 May; 130(5):2377-2390. PubMed ID: 31990686
[TBL] [Abstract][Full Text] [Related]
26. IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of
Xu B; Wu X; Gong Y; Cao J
Gut Microbes; 2021; 13(1):1968258. PubMed ID: 34432564
[No Abstract] [Full Text] [Related]
27. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.
Pawlowski SW; Calabrese G; Kolling GL; Platts-Mills J; Freire R; AlcantaraWarren C; Liu B; Sartor RB; Guerrant RL
J Infect Dis; 2010 Dec; 202(11):1708-12. PubMed ID: 20977342
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis.
Saavedra PHV; Huang L; Ghazavi F; Kourula S; Vanden Berghe T; Takahashi N; Vandenabeele P; Lamkanfi M
Nat Commun; 2018 Nov; 9(1):4846. PubMed ID: 30451870
[TBL] [Abstract][Full Text] [Related]
29. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
[TBL] [Abstract][Full Text] [Related]
30. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
Sun X; Hirota SA
Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
[TBL] [Abstract][Full Text] [Related]
31. A Practical Method for Preparation of Fecal Microbiota Transplantation.
Perez E; Lee CH; Petrof EO
Methods Mol Biol; 2016; 1476():259-67. PubMed ID: 27507347
[TBL] [Abstract][Full Text] [Related]
32. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.
Cowardin CA; Jackman BM; Noor Z; Burgess SL; Feig AL; Petri WA
Infect Immun; 2016 Aug; 84(8):2317-2323. PubMed ID: 27271747
[TBL] [Abstract][Full Text] [Related]
33. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
Girotra M; Garg S; Anand R; Song Y; Dutta SK
Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
[TBL] [Abstract][Full Text] [Related]
34. Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.
McDermott AJ; Frank CR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Gut Microbes; 2014 Jul; 5(4):476-84. PubMed ID: 25045999
[TBL] [Abstract][Full Text] [Related]
35. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
[TBL] [Abstract][Full Text] [Related]
36. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection.
Zackular JP; Moore JL; Jordan AT; Juttukonda LJ; Noto MJ; Nicholson MR; Crews JD; Semler MW; Zhang Y; Ware LB; Washington MK; Chazin WJ; Caprioli RM; Skaar EP
Nat Med; 2016 Nov; 22(11):1330-1334. PubMed ID: 27668938
[TBL] [Abstract][Full Text] [Related]
37. Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.
Spinler JK; Brown A; Ross CL; Boonma P; Conner ME; Savidge TC
Anaerobe; 2016 Aug; 40():54-7. PubMed ID: 27180007
[TBL] [Abstract][Full Text] [Related]
38. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
39. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
Wang L; Cao J; Li C; Zhang L
J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
[TBL] [Abstract][Full Text] [Related]
40. A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation.
Kim JE; Gweon TG; Yeo CD; Cho YS; Kim GJ; Kim JY; Kim JW; Kim H; Lee HW; Lim T; Ham H; Oh HJ; Lee Y; Byeon J; Park SS
World J Gastroenterol; 2014 Sep; 20(35):12687-90. PubMed ID: 25253977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
